Cargando…

Systemic Therapy of Neuroendocrine Neoplasia: Single Center Experience from a Cohort of 110 Consecutive Cases

OBJECTIVE: Neuroendocrine neoplasias (NENs) represent a rare and biologically heterogeneous group of malignancies. Treatment of NEN patients remains challenging due to lack of prospective evidence on the choice of ideal therapeutic sequence and therapeutic efficacy in specific individual scenarios....

Descripción completa

Detalles Bibliográficos
Autores principales:	Mayer, Karin, Kiry, Selina, Yordanova, Anna, Ahmadzadehfar, Hojjat, Gaertner, Florian C., Bundschuh, Ralph A., Essler, Markus, Gonzalez-Carmona, Maria A., Strassburg, Christian P., Matthaei, Hanno, Lingohr, Philipp, Bisht, Savita, Brossart, Peter, Feldmann, Georg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013359/ https://www.ncbi.nlm.nih.gov/pubmed/32089680 http://dx.doi.org/10.1155/2020/1491475

Ejemplares similares

Theranostics in nuclear medicine practice
por: Yordanova, Anna, et al.
Publicado: (2017)

Advances in Molecular Imaging and Radionuclide Therapy of Neuroendocrine Tumors
por: Yordanova, Anna, et al.
Publicado: (2020)

Role of textural heterogeneity parameters in patient selection for 177Lu-PSMA therapy via response prediction
por: Khurshid, Zain, et al.
Publicado: (2018)

Therapy of Patients with Neuroendocrine Neoplasia—Evidence-Based Approaches and New Horizons
por: Bundschuh, Ralph A., et al.
Publicado: (2019)

[(18)F]Fluorodeoxyglucose Positron Emission Tomography Reveals a Complete Remission of Refractory Metastatic Melanoma after Therapy with Ipilimumab
por: Yordanova, Anna, et al.
Publicado: (2017)

Biodistribution and post-therapy dosimetric analysis of [(177)Lu]Lu-DOTA(ZOL) in patients with osteoblastic metastases: first results
por: Khawar, Ambreen, et al.
Publicado: (2019)

Diagnostic accuracy of [(99m)Tc]Tc-Sestamibi in the assessment of thyroid nodules
por: Yordanova, Anna, et al.
Publicado: (2017)

Radioligand therapy of metastatic prostate cancer using (177)Lu-PSMA-617 after radiation exposure to (223)Ra-dichloride
por: Ahmadzadehfar, Hojjat, et al.
Publicado: (2017)

Assessment of Bone Metastases in Patients with Prostate Cancer—A Comparison between (99m)Tc-Bone-Scintigraphy and [(68)Ga]Ga-PSMA PET/CT
por: Thomas, Lena, et al.
Publicado: (2017)

Predictors of overall survival in metastatic castration-resistant prostate cancer patients receiving [(177)Lu]Lu-PSMA-617 radioligand therapy
por: Ahmadzadehfar, Hojjat, et al.
Publicado: (2017)

Uptake of PSMA-ligands in normal tissues is dependent on tumor load in patients with prostate cancer
por: Gaertner, Florian C., et al.
Publicado: (2017)

It is time to move forward into the era of Theranostics
por: Ahmadzadehfar, Hojjat, et al.
Publicado: (2018)

Combination Therapies with PRRT
por: Yordanova, Anna, et al.
Publicado: (2021)

Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches
por: Awang, Zool Hilmi, et al.
Publicado: (2018)

EF24 Suppresses Cholangiocellular Carcinoma Progression, Inhibits STAT3 Phosphorylation, and Induces Apoptosis via ROS-Mediated Oxidative Stress
por: Bisht, Savita, et al.
Publicado: (2019)

Evaluation of the delivered activity of yttrium-90 resin microspheres using sterile water and 5 % glucose during administration
por: Ahmadzadehfar, Hojjat, et al.
Publicado: (2015)

Therapeutic response and side effects of repeated radioligand therapy with (177)Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer
por: Ahmadzadehfar, Hojjat, et al.
Publicado: (2016)

Effect of Endobronchial Valve Therapy on Pulmonary Perfusion and Ventilation Distribution
por: Pizarro, Carmen, et al.
Publicado: (2015)

Assessing the quality of life of patients with metastatic castration-resistant prostate cancer with bone metastases receiving [(223)Ra]RaCl(2) therapy
por: Sraieb, Miriam, et al.
Publicado: (2020)

Case Report: Sustained complete remission on combination therapy with olaparib and pembrolizumab in BRCA2-mutated and PD-L1-positive metastatic cholangiocarcinoma after platinum derivate
por: Zhou, Taotao, et al.
Publicado: (2022)

Cyclin-Dependent Kinase 5 (CDK5) Controls Melanoma Cell Motility, Invasiveness, and Metastatic Spread—Identification of a Promising Novel therapeutic target()
por: Bisht, Savita, et al.
Publicado: (2015)

Estimating the Potential of Radiomics Features and Radiomics Signature from Pretherapeutic PSMA-PET-CT Scans and Clinical Data for Prediction of Overall Survival When Treated with (177)Lu-PSMA
por: Moazemi, Sobhan, et al.
Publicado: (2021)

Assessing the Effects of a Perioperative Nutritional Support and Counseling in Gastrointestinal Cancer Patients: A Retrospective Comparative Study with Historical Controls
por: Klassen, Diana, et al.
Publicado: (2023)

Preclinical Models of Neuroendocrine Neoplasia
por: Sedlack, Andrew J. H., et al.
Publicado: (2022)

Tumor Infiltrating Neutrophils Are Frequently Found in Adenocarcinomas of the Biliary Tract and Their Precursor Lesions with Possible Impact on Prognosis
por: Branchi, Vittorio, et al.
Publicado: (2021)

First Line and Second Line Chemotherapy in Advanced Cholangiocarcinoma and Impact of Dose Reduction of Chemotherapy: A Retrospective Analysis
por: Möhring, Christian, et al.
Publicado: (2021)

Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report
por: Koerber, Ruth-Miriam, et al.
Publicado: (2021)

A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies
por: Bisht, Savita, et al.
Publicado: (2016)

Conventional mesh repair of a giant iatrogenic bilateral diaphragmatic hernia with an enterothorax
por: Lingohr, Philipp, et al.
Publicado: (2014)

Exploring the Epigenome in Gastroenteropancreatic Neuroendocrine Neoplasias
por: Sharma, Rohini, et al.
Publicado: (2021)

A Combined TLR7/TLR9/GATA3 Score Can Predict Prognosis in Biliary Tract Cancer
por: Branchi, Vittorio, et al.
Publicado: (2021)

Hippo Signaling Mediates Proliferation, Invasiveness, and Metastatic Potential of Clear Cell Renal Cell Carcinoma()
por: Schütte, Ute, et al.
Publicado: (2014)

(177)Lu-DOTATATE and (177)Lu-prostate-specific membrane antigen therapy in a patient with advanced metastatic radioiodine-refractory differentiated thyroid cancer after failure of tyrosine kinase inhibitors treatment
por: Assadi, Majid, et al.
Publicado: (2019)

Gastric neuroendocrine neoplasias: manifestations and comparative outcomes
por: Felder, S, et al.
Publicado: (2019)

Landscape and Future Perspectives of Immunotherapy in Neuroendocrine Neoplasia
por: Maggio, Ilaria, et al.
Publicado: (2020)

Early side effects and first results of radioligand therapy with (177)Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study
por: Ahmadzadehfar, Hojjat, et al.
Publicado: (2015)

Diagnostic Value of Radiolabelled Somatostatin Analogues for Neuroendocrine Tumour Diagnosis: The Benefits and Drawbacks of [(64)Cu]Cu-DOTA-TOC
por: Vahidfar, Nasim, et al.
Publicado: (2022)

Cytokine expression in the visceral adipose tissue after laparoscopic and conventional surgery in a rodent model
por: Lingohr, Philipp, et al.
Publicado: (2016)

Complications of surgery for gastro-entero-pancreatic neuroendocrine neoplasias
por: Albers, Max B., et al.
Publicado: (2020)

Malignant melanoma of the ileo-anal pouch anastomosis after restorative proctocolectomy for ulcerative colitis: report of a case
por: Lingohr, Philipp, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6dmdn6k3fjt7c9mqjg7hvgniik